HSPA9 and cancer: Furthermore, immunostaining of mortalin exhibited shift in its staining pattern from perinuclear (typical of cancer cells) to pancytoplasmic (typical of normal cells) suggesting abgoration of mortalin-p53 complexes in Wi-A treated cells, as has also been demonstrated earlier [33–35].